These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 3236152)
1. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. Bodmeier R; McGinity JW J Microencapsul; 1988; 5(4):325-30. PubMed ID: 3236152 [TBL] [Abstract][Full Text] [Related]
2. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres. Bodmeier R; McGinity JW J Microencapsul; 1987; 4(4):289-97. PubMed ID: 3504510 [TBL] [Abstract][Full Text] [Related]
3. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology. Bodmeier R; McGinity JW J Microencapsul; 1987; 4(4):279-88. PubMed ID: 3504509 [TBL] [Abstract][Full Text] [Related]
4. The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Bodmeier R; McGinity JW Pharm Res; 1987 Dec; 4(6):465-71. PubMed ID: 3508558 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method. Yamakawa I; Tsushima Y; Machida R; Watanabe S J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728 [TBL] [Abstract][Full Text] [Related]
6. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. Lin SY; Chen KS; Teng HH; Li MJ J Microencapsul; 2000; 17(5):577-86. PubMed ID: 11038117 [TBL] [Abstract][Full Text] [Related]
7. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Freitas MN; Marchetti JM Int J Pharm; 2005 May; 295(1-2):201-11. PubMed ID: 15848005 [TBL] [Abstract][Full Text] [Related]
8. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. Lalla JK; Sapna K J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674 [TBL] [Abstract][Full Text] [Related]
9. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics. Jalil R; Nixon JR J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method. Uchida T; Nagareya N; Sakakibara S; Konishi Y; Nakai A; Nishikata M; Matsuyama K; Yoshida K Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1539-43. PubMed ID: 9332006 [TBL] [Abstract][Full Text] [Related]
11. [Preparation of sustained release microspheres containing extracts from Caulis sinomenii with polylactic acid and their release property in vitro]. Zhan W; Zhang X Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2142-5. PubMed ID: 21046749 [TBL] [Abstract][Full Text] [Related]
12. Functionality of protective colloids affecting the formation, size uniformity and morphology of drug-free polylactic acid microspheres. Lin SY; Chen KS; Teng HH J Microencapsul; 1998; 15(3):383-90. PubMed ID: 9608400 [TBL] [Abstract][Full Text] [Related]
13. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. Pavanetto F; Genta I; Giunchedi P; Conti B J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677 [TBL] [Abstract][Full Text] [Related]
17. Preparation of neurotensin analogue-containing poly(dl-lactic acid) microspheres formed by oil-in-water solvent evaporation. Yamakawa I; Tsushima Y; Machida R; Watanabe S J Pharm Sci; 1992 Sep; 81(9):899-903. PubMed ID: 1432637 [TBL] [Abstract][Full Text] [Related]
18. [Effect of morphological properties on drug release from biodegradable microspheres]. Takeshima K; Sunagawa N; Nagata S; Hirano K; Takagishi Y Yakugaku Zasshi; 1992 Mar; 112(3):203-10. PubMed ID: 1608045 [TBL] [Abstract][Full Text] [Related]
19. Salt and cosolvent effects on ionic drug loading into microspheres using an O/W method. Al-Maaieh A; Flanagan DR J Control Release; 2001 Jan; 70(1-2):169-81. PubMed ID: 11166417 [TBL] [Abstract][Full Text] [Related]
20. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics. Wakiyama N; Juni K; Nakano M Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2621-8. PubMed ID: 7139823 [No Abstract] [Full Text] [Related] [Next] [New Search]